470478-90-1

Basic information

• Product Name: 4-(4-TERT-BUTOXYCARBONYLPIPERAZINYL)PHENYLBORONIC ACID, PINACOL ESTER
• Synonyms: TERT-BUTYL 4-[4-(4,4,5,5-TETRAMETHYL-1,3,2-DIOXABOROLAN-2-YL)PHENYL]TETRAHYDRO-1(2H)-PYRAZINECARBOXYLATE;4-(4-TERT-BUTOXYCARBONYLPIPERAZINYL)PHENYLBORONIC ACID, PINACOL ESTER;4-[4-(TERT-BUTOXYCARBONYL)PIPERAZIN-1-YL]PHENYLBORONIC ACID PINACOL ESTER;4(N-TERT-BUTOXYCARBONYLPIPERAZINE)BENZENEBORONIC ACID PINACOL ESTER;4-Piperazin-1-ylbenzeneboronic acid pinacol ester, N4-BOC protected;Tert-butyl4-(4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)tetrahydro-1(2H)-pyrazinecarboxylate;4-[4-(N-Boc)piperazin-1-yl]phenylboronic acid pinacol ester;t-butyl 4-[4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]piperazinecarboxylate
• CAS NO: 470478-90-1
• Molecular Formula: C₂₁H₃₃BN₂O₄
• Molecular Weight: 388.31
• Product Categories: Aryl;Boronic ester;Organoborons
• Mol File: 470478-90-1.mol
• Article Data: 15

Chemical Properties

• Melting Point: 157 °C
• Boiling Point: 501.7 °C at 760 mmHg
• Flash Point: 257.2 °C
• Appearance: /
• Density: 1.11
• Vapor Pressure: 3.4E-10mmHg at 25°C
• Refractive Index: 1.536
• Storage Temp.: Keep in dark place,Sealed in dry,Room Temperature
• PKA: 3.06±0.10(Predicted)
• CAS DataBase Reference: 4-(4-TERT-BUTOXYCARBONYLPIPERAZINYL)PHENYLBORONIC ACID, PINACOL ESTER(CAS DataBase Reference)
• NIST Chemistry Reference: 4-(4-TERT-BUTOXYCARBONYLPIPERAZINYL)PHENYLBORONIC ACID, PINACOL ESTER(470478-90-1)
• EPA Substance Registry System: 4-(4-TERT-BUTOXYCARBONYLPIPERAZINYL)PHENYLBORONIC ACID, PINACOL ESTER(470478-90-1)

Safety Data

• Statements: 36/37/38
• Safety Statements: 26-36
• Hazardous Substances Data: 470478-90-1(Hazardous Substances Data)

Usage

Uses

tert-Butyl 4-(4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)piperazine-1-carboxylate (cas# 470478-90-1) is a useful reactant for the preparation of 211At- and 125I-?radiolabeled compounds.

InChI:InChI=1/C21H33BN2O4/c1-19(2,3)26-18(25)24-14-12-23(13-15-24)17-10-8-16(9-11-17)22-27-20(4,5)21(6,7)28-22/h8-11H,12-15H2,1-7H3

Upstream product

• 374930-88-8 tert-butyl 4-(5-bromopyrimidin-2-yl)piperazine-1-carboxylate 
• 73183-34-3 bis(pinacol)diborane 
• 24424-99-5 di-tert-butyl dicarbonate 
• 66698-28-0 1-(4-bromophenyl)piperazine 
• 909418-89-9 tert-butyl 4-(4-(methylthio)phenyl)piperazine-1-carboxylate 
• 104-95-0 (4-bromophenyl)thioanisole 
• 57260-71-6 1-t-Butoxycarbonylpiperazine 
• 106-37-6 1.4-dibromobenzene 
• 589-87-7 1,4-bromoiodobenzene 
• 352437-09-3 tert-butyl 4-(4-bromophenyl)piperazine-1-carboxylate 

Downstream Products

• 1062368-25-5 C₂₁H₂₅N₅O₂ 
• 1062368-36-8 methyl 6-(4-piperazin-1-ylphenyl)pyrazolo[1,5-a]pyridine-3-carboxylate 
• 1355702-83-8 C₁₇H₁₇ClN₄ 
• 1379522-35-6 tert-butyl 4-(4-{[4-(methylsulfonyl)benzyl]oxy}phenyl)piperazine-1-carboxylate 
• 158985-25-2 tert-butyl 4-(4-hydroxyphenyl)piperazine-1-carboxylate 
• 1374342-25-2 ethyl 1-{6-[4-methyl-4'-(piperazin-1-yl)biphenyl-2-yl]pyridin-2-yl}-5-(trifluoromethyl)-1H-pyrazole-4-carboxylate 
• 1374339-40-8 1-(6-{4'-[4-(cyclopropylsulfonyl)piperazin-1-yl]-4-methylbiphenyl-2-yl}pyridin-2-yl)-5-(trifluoromethyl)-1H-pyrazole-4-carboxylic acid 
• 1374339-41-9 1-{6-[4'-(4-cyclopropylpiperazin-1-yl)-4-methylbiphenyl-2-yl]pyridin-2-yl}-5-(trifluoromethyl)-1H-pyrazole-4-carboxylic acid 
• 1374339-42-0 1-[6-(4'-{4-[(3,3-difluorocyclobutyl)carbonyl]piperazin-1-yl}-4-methylbiphenyl-2-yl)pyridin-2-yl]-5-(trifluoromethyl)-1H-pyrazole-4-carboxylic acid 
• 1374339-43-1 1-(6-{4'-[4-(cyclopropylmethyl)piperazin-1-yl]-4-methylbiphenyl-2-yl}pyridin-2-yl)-5-(trifluoromethyl)-1H-pyrazole-4-carboxylic acid 
• 1374342-26-3 C₃₄H₃₆F₃N₅O₄ 

Relevant articles and documents

Nucleophilic18F-Labeling of Spirocyclic Iodonium Ylide or Boronic Pinacol Ester Precursors: Advantages and Disadvantages

The field of labeling electron-rich aryl compounds with nucleophilic [18F]fluoride has recently expanded with radiofluorination strategies that apply boronic esters or spirocyclic iodonium ylides as precursors. Herein, we present a direct compa

RET INHIBITORS, PHARMACEUTICAL COMPOSITIONS AND USES THEREOF

Provided herein are a RET inhibitor, a pharmaceutical composition thereof and uses thereof. In particular, provided is a compound having Formula (I) or a stereoisomer, a geometric isomer, a tautomer, an N-oxide, a solvate, a metabolite, a pharmaceutically acceptable salt or a prodrug thereof. Provided is a pharmaceutical composition comprising the compound, and uses of the compound and pharmaceutical composition thereof for the preparation of a medicament, in particular for treatment and prevention of RET-related diseases and conditions, including cancer, irritable bowel syndrome, and/or pain associated with irritable bowel syndrome.

Substituted piperazine compounds and method and use thereof

The invention relates to a new piperazine compound and a drug composition comprising the compound, which are used for inhibiting 5-hydroxytryptamine reuptake and/or agonizing 5-HT1A receptors. The invention also relates to methods for preparing the compou